OOIR: Observatory of International Research

Papers

(The H4-Index of Current Opinion in Immunology is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Gene: environment interactions in immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2 infection	279
An easy pill to swallow: oral recombinant vaccines for the 21st century	98
Mechanistic insights into epigenetic contributions to psoriasis pathogenesis and their clinical implications	93
AP-1 transcription factors in cytotoxic lymphocyte development and antitumor immunity	85
Principles and practical applications of structure-based vaccine design	74
Oncogenic viruses, cancer biology, and innate immunity	71
Better living through chemistry: CRISPR/Cas engineered T cells for cancer immunotherapy	68
TAP-ing into the cross-presentation secrets of dendritic cells	68
The future of vaccination in Latin America: learning from the COVID-19 pandemic	67
Can juvenile idiopathic arthritis be cured?	60
Mycobacterial diseases in patients with inborn errors of immunity	60
Inflammasome activation by SARS-CoV-2 and its participation in COVID-19 exacerbation	60
Revisiting the role of MRGPRX2 on hypersensitivity reactions to neuromuscular blocking drugs	57
Host genetics of innate immune system in infection	53
Pharmacotherapeutic strategies to promote regulatory T cell function in autoimmunity	51
Safety switches for adoptive cell therapy	49
Beyond the gastric epithelium — the paradox of Helicobacter pylori-induced immune responses	48
Innate antiviral immunity and immunometabolism in hepatocytes	46
Commander-in-chief: monocytes rally the troops for defense against aspergillosis	44
Some thoughts about what non-mammalian jawed vertebrates are telling us about antigen processing and peptide loading of MHC molecules	44
Can we cure Behçet syndrome?	44
B cell–targeted therapies in autoimmune skin disease: current advances and challenges	42
Can sarcoidosis be cured?	42
Complement in antiphospholipid syndrome, time to target?	42
Neuropsychiatric lupus: a myriad of symptoms requires a myriad of models	42

Regulation of MHC class II and CD86 expression by March-I in immunity and disease	41
Nutritional modulation of antitumor immunity	40
Metabolism and macrophages in the tumor microenvironment	40
Necroptosis in immunity, tissue homeostasis, and cancer	40
Immunological lessons from genome-wide association studies of infections	39
Mechanistic considerations linking SARS-CoV-2 infection, inflammation, and the loss of immune tolerance	39
Animal models of autoimmune encephalitis	38
Can we cure bullous skin diseases?	32
Mapping and modelling human B cell maturation in the germinal centre	32